The trichothecene mycotoxin deoxynivalenol (DON), a frequent contaminant of cereal grains, is known to dysregulate mucosal and systemic immunity. In this study, we tested the hypothesis that DON interferes with the murine immune response to viral respiratory infection. Female Balb/c mice (5 weeks old) were orally gavaged with DON (10 mg/kg body weight [bw]) or saline vehicle and then intranasally instilled with 10 7 plaque-forming units of reovirus serotype 1, strain Lang (T1/L). At 10-day postinstillation (PI), both viral titers and reovirus L 2 gene expression were 10-fold higher in lungs of DON-treated mice than in saline controls. The lowest observed effective DON dose that impaired viral clearance was 2 mg/kg bw. Although DON amplified reovirus-induced interferon (IFN)-b and IFN-g mRNA responses in lung, the toxin suppressed mRNA expression for IFN-a, IFN-ab receptor (IFNAR), and IFN-g receptor (IFNGR). DON also impaired induction of two type 1 IFNdependent antiviral genes, double-stranded RNA activated protein kinase R (PKR) and oligoadenylate synthase 2 (OAS2). Respiratory reovirus infection caused a mild bronchopneumonia in mice which was markedly exacerbated by DON as evidenced by severe inflammatory cell infiltration, marked alveolar damage, and a higher volume density of intraepithelial mucosubstances in pulmonary airways. At 3-and 7-day PI, elevations in total protein, MCP-1, TNF-a, total cells, macrophages, neutrophils, and lymphocytes were observed in bronchoalveolar lavage fluid (BALF) of control mice infected with reovirus. DON markedly enhanced viral-induced elevations of protein, MCP-1, TNF-a, and inflammatory cells in the BALF at 3-day PI. DON exposure also upregulated induction of reovirus-specific immunoglobulin A (IgA) in BALF, fecal pellets, and serum. DON's effect on BALF IgA was preceded by elevated IL-6 expression and secretion in the lung. Taken together, the results suggest that DON compromised resistance to respiratory viral infection. Reduced expression of IFNAR and type 1 IFN-mediated genes in the lung might contribute to DON impairment of pulmonary reovirus clearance, whereas exacerbation of bronchopneumonia and IgA responses corresponded to increased MCP-1, TNF-a, and IL-6 expression.
Deoxynivalenol (DON or ''vomitoxin'') is a type B trichothecene mycotoxin that commonly occurs in wheat, barley, and corn following infection in the field by the fungus Fusarium graminearum (Bai and Shaner, 2004) . DON and other trichothecenes target leukocytes and are further capable of dysregulating immune function (Pestka and Smolinski, 2005) . At the molecular level, DON induces phosphorylation of mitogenactivated protein kinases (MAPKs) via a mechanism known as the ribotoxic stress response (Pestka et al., 2004) . MAPK activation modulates expression of genes associated with immune response, chemotaxis, inflammation, and apoptosis (Chung et al., 2003a,b; Pestka 2002, 2003; Zhou et al., 2003a Zhou et al., ,b,c, 2005a .
DON and other trichothecenes can both enhance and suppress systemic responses to experimental infections by Salmonella (Bottex et al., 1990; Kubena et al., 2001; Tai and Pestka, 1990; Ziprin and Elissalde, 1990) , Listeria (Corrier et al., 1987; Ziprin and McMurray, 1988) , Staphylococcus (Cooray and Jonsson, 1990) , and herpes simplex virus (Friend et al., 1983a,b) .
Trichothecenes have also been shown to suppress mucosal immune function. Reovirus, a double-stranded RNA virus isolated from respiratory and gastrointestinal (GI) systems of human and animals induces marked cellular and humoral responses (Tyler et al., 2001) , making it useful to study the mucosal effects and mechanisms of immunotoxicants (Cuff et al., 1998) . When oral exposure to reovirus was used to investigate the suppressive effects of DON and the type A trichothecene, T-2 toxin, on GI mucosal immunity in the mouse, doses as low as 2 and 0.2 mg/kg body weight (bw) of these toxins, respectively, depressed interferon (IFN)-c expression and increased intestinal reovirus burden (Li et al., 2005 (Li et al., , 2006a .
Reoviruses might also be useful for studying whether trichothecene exposure interferes with immune responses at another critical mucosal site-the respiratory tract. Airway exposure to reovirus causes murine lung infection in the mouse which generates a spectrum of age-and strain-dependent immunopathologic and inflammatory sequelae London et al., 2002a,b; Majeski et al., 2003a,b; Morin et al., 1996) . Notably, reovirus infection evokes only mild pulmonary inflammation in C3H mice (London et al., 2002a; Periwal and Cebra, 1999) but causes a more severe inflammation in Balb/c or CD-1 mice (Thompson et al., , 1999 . Reovirus-infected CBA/J mice exhibit the most severe pathologic effects which closely mimic bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome.
Recently, we determined that T-2 toxin suppresses murine host resistance to respiratory infection by reovirus in Balb/c mice (Li et al., 2006b) . Given the frequent occurrence of DON in foods (Abouzied et al., 1991; Pestka and Smolinski, 2005) , it is important from the perspective of safety assessment to understand how this mycotoxin might affect viral respiratory infection. This is particularly critical since studies with the enteric reovirus model suggest that inherent differences exist between T-2 and DON relative to minimum effective doses and virus persistence as well as immunoglobulin A (IgA) and cytokine responses (Li et al., 2005 (Li et al., , 2006a . The objective of this research was to test the hypothesis that DON exposure impairs the murine immune response to respiratory reovirus infection. Specifically, we assessed the effects of a single oral exposure to DON on reovirus clearance, lung injury, and IgA responses. Acute DON exposure not only impaired reovirus clearance but markedly exacerbated reovirus-induced inflammation and pulmonary damage. These effects corresponded to suppression of type 1 IFN-mediated responses, upregulation of proinflammatory cytokine and chemokine expression, and elevated IgA responses in the lung.
MATERIALS AND METHODS
Chemicals and animals. All chemicals including DON and tissue culture components were purchased from Sigma Chemical Co (St Louis, MO) unless otherwise noted. Female Balb/c mice were purchased from Charles River Labs (Portage, MI). Mice were housed in microisolator cages under negative pressure laminar flow with humidity and temperature control at the MSU University Research Containment Facility. All animal studies were overseen by the Michigan State University Committee on Animal Use and Care and followed National Institutes of Health (NIH) guidelines.
Virus. Reovirus serotype 1, strain Lang (T1/L), was grown in L929 fibroblast cells at 34°C in DMEM medium with 5% (vol/vol) fetal bovine serum, 100 U/ml of penicillin, 100 lg/ml of streptomycin, and 0.25 lg/ml of amphotericin B (Invitrogen, Carlsbad, CA). Virions were purified as described previously (Furlong et al., 1988; Silvey et al., 2001) . Virus titers were determined by a plaque-forming assay (Major and Cuff, 1997) .
Experimental design. DON was dissolved in endotoxin-free water. For most experiments, 5-week-old BALB/c female mice were orally gavaged with 10 mg/kg bw DON or vehicle in a 100-ll volume using a 22 G intubation needle (Popper and Sons, New Hyde Park, NY). For the dose-response study, mice were gavaged with DON 0, 2, 5, 10, or 25 mg/kg bw or vehicle in a 100-ll volume. After 2 h, mice were lightly anesthetized with isoflurane (Abbott Labs, North Chicago, IL) and intranasally instilled with 1 3 10 7 plaque-forming units (PFU) of reovirus 1/l in a total volume of 30 ll (15 ll per nostril) of sterile injectable grade saline. Control animals were instilled with 30 ll (15 ll per nostril) of the saline vehicle. Fecal pellets were collected at 0-, 2-, 4-, 6-, 8-, and 10-day PI. Pellets were weighed and suspended in phosphate-buffered saline (PBS, 10% [wt/vol] ), held on ice for 2 h, sonicated for 15 s, and cleared by high-speed centrifugation for 10 min at 4°C. Supernatants were used directly for specific antibody detection by ELISA.
Mice were killed 10 days after intranasal instillation. At the time of necropsy, each animal was anesthetized with an ip injection 100 ll of sodium pentobarbital 12% (wt/vol). After induction of anesthesia, a midline laparotomy was performed, and the mouse was exsanguinated via the abdominal aorta. Immediately after death, the trachea was exposed and cannulated, and the heart and lung were excised en bloc. The right extrapulmonary bronchus was ligated, and the right cranial and middle lung lobes were excised and stored at 20°C for later processing for virus quantitation by plaque-forming assay. Right caudal and accessory lobes were removed and then immersed and stored in RNAlater solution (Ambion, Inc., Austin, TX) until further processing to extract RNA from the lung tissue.
Following removal of the right lung lobes, the left lung lobe was intratracheally perfused with 10% (wt/vol) neutral buffered formalin at a constant pressure of 30 cm of fixative. After 1 h, the trachea was ligated, and the inflated left lung lobe was immersed in a large volume of the same fixative for at least 24 h. After fixation, the left lobe was microdissected along the main axial airway, and two transverse tissue blocks were excised at the level of the fifth (proximal) and eleventh (distal) airway generation (G5 and G11, respectively) for further processing, as has been previously reported (Farraj et al., 2003) . Tissue blocks were embedded in Immuno-Bed plastic embedding media (Polysciences, Inc., Warrington, PA), and the anterior surface of each block was cut at a thickness of 2-3 microns using a glass knife. Lung sections were stained with hematoxylin and eosin for routine light microscopic examination or alcian blue (pH 2.5)/periodic acid Schiff sequence (AB/PAS) for detection of stored intraepithelial mucosubstances in the conducting airways.
To further investigate inflammatory cell and cytokine responses to reovirus and DON, additional mice were treated with 0 or 10 mg/kg bw DON and reovirus as described above, but bronchoalveolar lavage fluid (BALF) was collected postmortem at 3-and 7-day PI in situ by intratracheal instilling and withdrawing 1 ml of PBS twice with an intubation cannula (22 G). Samples were pooled from each animal.
Quantitation of reovirus L 2 gene. Total RNA was extracted from lung using TRIZOL reagent (Invitrogen). Reverse transcriptase reaction and realtime PCR were performed as described previously (Li et al., 2005) using PCR primers selected from published sequence of k 2 core spike (L 2 gene) of reovirus T1/L (Breun et al., 2001) (Table 1) .
Real-time PCR quantitation of antiviral and inflammation-related genes. Real-time PCR for antiviral and inflammation-related genes was performed as previously described (Kinser et al., 2004) using primer sequences that were designed from GenBank sequences (Table 1) .
Semiquantitative scoring of lung histopathology. A board-certified, veterinary pathologist, without previous knowledge of exposure history of the individual mice, conducted the light microscopic examinations and ranked the severity of treatment-induced pulmonary histopathology in the lung sections of each mouse using a criteria-based numeric scoring system. A score of 0 was given when no exposure-related lung lesions were observed in the sections. If an exposure-related morphologic alteration affected less than one fourth of the lung section, it was given a histopathologic severity score of 1 (minimal). When exposure-related alterations involved greater than one fourth, but less than on half of the lung section, it was scored as 2 (mild). A severity score of 3 (moderate) was given when the exposure-induced lesions involved more than one half but less than three fourths of the lung section. If induced morphologic alterations affected greater than three fourths of the lung section, it was given a severity score of 4 (marked).
Morphometry. Quantitative analyses for the volume densities of mucosubstances stored in surface epithelium lining the axial airway of the left lung lobe were made using G5 lung sections stained with AB/PAS to identify acidic (AB positive; blue stain) and neutral (PAS positive; red stain) mucosubstances within mucous goblet cells. A semiautomatic computerized image analysis (Harkema et al., 1997) was used to make these measurements. The area of AB/ PAS-positive intraepithelial mucosubstances was calculated by the image analysis software program from the manually or automatically circumscribed perimeter of the stained material. The method used to estimate the amount of stored mucosubstance per unit length of surface area of epithelial basal lamina (volume density per surface area) has been previously described in detail (Harkema et al., 1987) .
Analysis of BALF.
Total leukocytes in BALF were counted with a hemocytometer, and fractions of neutrophils, macrophages, and lymphocytes were determined in cytospin samples with Diff-Quik reagent (Baxter, Miami, FL). IL-6, IL-10, MCP-1, IFN-c, TNF-a, and IL-12p70 concentration in BALF were determined with a Cytometric Bead Array Mouse Inflammation Kit (BD, Biosciences, San Diego, CA) according to manufacturer's instructions using a FACScalibur and BD CBA Analysis Software (BD Bioscience, San Jose, CA). Assay sensitivities for these analytes were 5, 17.5, 52.7, 2.5, 7.3, and 10.7 pg/ml, respectively.
Detection of reovirus-specific IgA. BALF, fecal supernatant, and serum were assayed for virus-specific IgA by ELISA using a modification of the procedure of Major and Cuff (1997) . Absorbance at 450 nm was used as end point for BALF and fecal suspensions. For sera, titers were designated as the highest serum dilution that yielded absorbances of 0.2 or higher; the geometric mean antibody titer was then calculated.
Statistics. All data were analyzed with SigmaStat v 3.1 (Jandel Scientific; San Rafael, CA) with the criterion for significance set at p < 0.05. Morphometric and real-time PCR data were statistically analyzed using oneway ANOVA with Student-Newman-Keuls posttest. Data from histopathological severity of treatment-induced lesions were analyzed using the Mann Whitney Rank Sum Test (nonparametric test).
RESULTS

Reovirus Clearance from Lung
To test the capacity of DON to modulate reovirus respiratory infection, 5-week-old female BALB mice were intubated with 10 mg/kg bw DON or water vehicle and then intranasally instilled 2 h later with reovirus or saline vehicle. After 10 days, viral titers and virus RNA expression of lung in infected mice pretreated with water vehicle were approximately 10 5 PFU/ lung ( Fig. 1A ) and 200 copies L 2 gene/lg total lung RNA ( Fig.  1B) , respectively. However, in DON-treated mice, both PFU and L 2 gene copy number were 10 times higher. When the dose-response effects of DON on L 2 RNA in lung were assessed 3 days PI, the mycotoxin was found to significantly elevate L 2 RNA expression in lung at 2, 5, 10, and 25 mg/kg bw ( Fig. 2) . Thus, as little as 2 mg/kg DON increased the reovirus burden in lung early during the infection.
Type 1 IFN Antiviral Response
Since IFN-a, IFN-b, and other type I IFNs play a critical role in the early innate antiviral response (Garcia-Sastre and Biron, 2006) , expression of genes that mediated his response were monitored in the lung after treatment with DON and/or reovirus (Fig. 3 ). IFN-a expression was suppressed by DON at 3-and 7-day PI and by reovirus at 3 days, and the suppression was magnified at 3 days following coexposure (Figs. 3A and 3B) . In contrast, reovirus-induced mRNA expression of IFN-b in lungs was enhanced by DON at 3-day PI but not at 7-day PI (Figs. 3C and 3D). DON alone markedly suppressed mRNA expression of IFN-ab receptor (IFNAR), a type 1 IFN receptor, in the lungs of both uninfected mice after 3 days and reovirusinfected mice after 3 and 7 days (Figs. 3E and 3F) .
Respiratory reovirus infection also induced expression of mRNAs for several type 1 IFN-driven antiviral genes including 2#-5# oligoadenylate synthase 2 (OAS2), double-stranded RNA activated protein kinase R (PKR), the myxovirus resistance gene Mx1, and ubiquitin-like protein ISG15 in lungs at 3-and 7-day PI (Fig. 4) . In virus-infected mice pretreated with DON, OAS2 mRNA expression was impaired at 7-day PI (Figs. 4A and 4B) and PKR mRNA expression was suppressed at 3-and 7-day PI (Figs. 4C and 4D ). Induction of Mx1 and ISG15 mRNAs were unaffected by DON (Figs. 4E-4H ). Thus, DON-induced suppression of IFNAR expression corresponded to interference with type 1 IFN-mediated OAS2 and PKR antiviral pathways. 
IFN-c and IFN-c receptor Expression
IFN-c is also very important to the antiviral response and is produced as part of innate and acquired immune responses (Biron and Sen, 2001 ). Reovirus did not induce detectable IFNc protein secretion or IFN-c mRNA expression in the lung at 3-day PI (data not shown). However, both parameters were upregulated 100-and 30-fold, respectively, at 7-day PI (Figs.  5A and 5B), suggesting that IFN-c might be produced as part of the acquired response in this model. DON exposure markedly enhanced both IFN-c protein and mRNA responses at 7-day PI. In contrast, DON suppressed mRNA expression of IFN-c receptor (IFNGR) expression in reovirus-infected mice at 3-day PI (Fig. 5C ). By 7-day PI, IFNGR expression was markedly suppressed in reovirus-infected mice, but DON did not further modulate this suppressive effect (Fig. 5D ).
Reovirus-Induced Lung Pathology
No pulmonary histopathology was evident in mice exposed to DON alone or control mice exposed only to the saline vehicle (Figs. 6A-6D ). Incidence and severity of lung lesions were greatest in the mice exposed to both reovirus and DON. At 10-day PI, all the mice in this group had either a mild or moderate, subacute bronchopneumonia. This airway orientated lung lesion was characterized by a peribronchial mononuclear inflammatory cell infiltrate, composed mainly of large and small lymphocytes and monocytes. The airway inflammation was centered around the large-diameter, main axial conducting airway but extended also into the more distal, small-diameter, preterminal and terminal bronchioles, proximal alveolar ducts, and alveolar septa and airspaces in the adjacent alveolar parenchyma (Fig. 6D) . Perivascular cuffing of inflammatory cells was also present in these areas as well as increased numbers of alveolar macrophages/monocytes in the affected alveolar airspaces. The inflammatory response, however, rarely extended to the outer pulmonary pleura. There was a noticeable proximal to distal decrease in the severity of the bronchopneumonia in the lung lobe of each animal with more inflammatory lesions in the proximal lung section (G5 axial airway level; closest to the hilus) compared to the more distal section (G11 axial airway level).
Interestingly, only two of the five mice exposed to reovirus alone had histopathologic evidence of a viral-induced mononuclear cell bronchopneumonia at 10-day PI. The extent and severity of the lung lesions in these mice were less than that in the mice that were exposed to both reovirus and DON (Figs. 6E and 6F).
Reovirus-Induced Mucous Cell Metaplasia
Associated with the inflammatory response, there was mild hypertrophy and mucous cell metaplasia in the respiratory epithelium lining the main axial airway and minimal to mild alveolar type two cell hyperplasia lining some of the affected alveolar septa. The amount of AB/PAS-stored mucosubstances in this airway epithelium of reovirus-infected mice was markedly less than that measured in the mice coexposed to reovirus and DON (Figs. 7A-7D ). There was approximately three times the level AB/PAS-stained mucosubstances in the airway epithelium lining the G5 axial airway of these coexposed mice compared to that morphometrically measured in similar airways of saline-instilled control mice (Fig. 7E) .
Reovirus-Induced Leukocyte Migration to the Alveolar Space
To further understand the mechanisms by which DON contributes to lung inflammation in reovirus-infected mice, BALF cellularity was evaluated (Table 2 ). Exposure to reovirus alone caused marked increases in total cell, macrophage, neutrophil, and lymphocyte numbers at 3-and 7-day PI. Both macrophage and total inflammatory cell number in the BALF from mice exposed to DON alone were increased markedly at 3-day PI but recovered by 7-day PI. DON potentiated migration of lymphocytes and total cells into the BALF of reovirus-treated mice after 3 days, with a similar trend being evident for neutrophils. By 7 days, total cell numbers in BALF of cotreated mice were greatly elevated compared to the reovirus group with macrophages and neutrophils primarily contributing to this increase. These increases were accompanied by a decrease in the 
Protein and Cytokine Secretion into Alveolar Space Following Reovirus Infection
BALF protein concentrations in saline-and DON-treated control mice did not differ after 3 and 7 days (Figs. 8A and 8B). Reovirus infection induced protein secretion at 3-and 7-day PI, whereas protein concentrations were 4-and 1.5-fold higher at 3-and 7-day PI, respectively, in DON-treated mice infected with reovirus. Respiratory reovirus infection also induced secretion of the chemokine MCP-1 (Figs. 8C and 8D ) and the proinflammatory cytokine TNF-a at 3-and 7-day PI (Figs. 8E and 8F) into alveolar airspaces but did not induce IL-10 or IL-12 (data not shown). DON pretreatment in reovirus-infected mice, potentiated production of MCP-1 at 3-day PI and TNF-a at 3-and 7-day PI as compared to saline-treated infected mice. Thus, prior DON exposure enhanced protein, MCP-1, and TNF-a concentrations in the BALF of reovirus-infected mice.
Mucosal and Systemic IgA Response to Respiratory Reovirus Infection
Reovirus-specific IgA responses in BALF and feces were measured as an indicator of lung and gut mucosal responses, respectively. The virus induced robust IgA responses in both tissues which were amplified by DON in BALF at 7-day PI (Fig. 9A ) and in fecal supernatants from 6-to 10-day PI (Fig.  9B) . Similarly, DON enhanced reovirus-specific IgA titers in serum (Fig. 9C) . DON is known to potently upregulate IgA secretion in the mouse, and this upregulation is driven by increased IL-6 expression (reviewed by Pestka, 2003) . Reovirus induced IL-6 mRNA expression in lung tissue and IL-6 secretion into BALF at 3-and 7-day PI (Figs. 10A-10D ). Exposure to DON amplified IL-6 mRNA expression and IL-6 secretion at 3 days (Figs. 10A and 10C) but not 7 days (Figs.  10B and 10D) . The results suggested that DON potentiated reovirus-induced IgA responses to respiratory reovirus infection and, in the lung, these effects were preceded by elevated IL-6 expression.
DISCUSSION
Immunotoxic chemicals have the potential to increase susceptibility to the viral respiratory infections by modulating mucosal and systemic immune responses. DON has a unique capacity to up-and down-regulate immune function by disrupting intracellular signaling within leukocytes (Pestka et al., 2004) . In this study, reovirus was chosen to investigate effects of DON on respiratory immune response because it (1) causes a range of pathological changes in the lungs of mice depending on the age, species, and viral dose (Thompson et al., , 1999 , (2) induces a robust mucosal immune responses (Cuff et al. 1998) , (3) has been widely used a model for viral pathogenesis (Tyler et al., 2001, (4) has recently been shown to cause bronchiolitis and aveolitis in mice exposed to T-2 toxin (Li et al., 2006b) , and (5) presents a minimal risk to laboratory personnel or laboratory animal facilities. The results of the present study demonstrate that intranasal exposure to reovirus initiated mild bronchopneumonia in 5-week-old Balb/c mice. However, infection of DON-treated mice increased lung reovirus burden and suppressed virus clearance from the infected lung. In addition, more severe histopathological FIG. 6 . Light photomicrographs of pulmonary tissue from the left lung lobe. Sections were prepared 10 days after intranasal instillation with saline vehicle alone (A), reovirus alone (B), DON alone (C), or reovirus and DON (D) as described in Figure 4 legend. Increased cellularity around conducting airways (arrows), including the main axial airway (AA) at generation 5 and terminal bronchioles (TB), is due to a mononuclear inflammatory cell infiltrate (mainly large and small lymphocytes and monocytes) and is present in the lungs of mice exposed to reovirus (B and C). Unlike the minimal inflammatory cell response in the lungs of mouse exposed only to reovirus (B), there is a moderate/marked inflammatory cell response (asterisk) that extends into the alveolar ducts (AD) and alveolar parenchyma (AP) in the lungs of the mouse exposed to both reovirus and DON (D). BV, blood vessel. G5 (E) and G11 (F) in the left lung lobes were histopathologically scored for of pulmonary inflammation 10 days after treatment with DON and/or reovirus. Data are mean scores ± SEM (n ¼ 6). Bars without same letter differ significantly (p < 0.05).
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at Pennsylvania State University on February 21, 2013 http://toxsci.oxfordjournals.org/ changes were evident in lung with marked exacerbation of inflammatory cell infiltration and mucous metaplasia in conducting airways. The finding that as little as 2 mg/kg bw DON suppressed host resistance to reovirus in the lung is consistent with our previous observations in the intestinal model (Li et al., 2005) .
While most reovirus infections are asymptomatic in humans, this virus can cause mild respiratory or GI symptoms that are virtually indistinguishable from upper respiratory infections and diarrheal illnesses often encountered during infancy and early childhood (Tyler, 2001) . The capacity of DON to exacerbate bronchopneumonia in young reovirus-infected mice is very important because the toxin might similarly exacerbate asymptomatic or mild human infections by reovirus or other viruses.
Immunity to reovirus and other viruses includes both innate and adaptive components. These typically involve cell-mediated and antibody effector responses that are finely regulated by cytokines. IFNs play a particularly critical role in immunity by binding to surface receptors on effector cells and inducing transcription of genes that mediate antiviral responses (Goodbourn et al., 2000) . IFN-a and IFN-b induce several antiviral genes that include PKR, OAS 2, and Mx proteins (Garcia-Sastre and Biron, 2006) . Both PKR and OAS pathways can be activated by viral double-stranded RNA. Upon activation, PKR will shut down viral and protein translation, while OAS can activate RNase L which digests viral RNA and mRNA. The observations that DON exposure reduced mRNA levels of PKR and OAS2 in DON-treated mice following infection were consistent with depressed IFN-a and IFNAR expression as well as with the elevated viral titers observed in lung tissue. Several questions arise from these observations. Typically, these innate mechanisms play a very important role within the first 72-96 h following infection. Since the effects observed here occurred later (7 days), it is not readily apparent whether DON directly impairs these important antiviral pathways or if they are downstream consequences of an earlier event. It should be further noted that the effects of DON on IFNAR, PKR, and OAS2 were FIG. 7 . Light photomicrographs of respiratory epithelium lining the axial airway at generation 5 in pulmonary tissue at 10-day PI from the left lung lobe of mice intranasally instilled with saline vehicle alone (A), reovirus alone (B), DON alone (C), or reovirus and DON (D) as described in Figure 4 legend. Mucus-producing cells (arrows) in airways were increased in DON-treated mice after reovirus infection. Mucus-producing cells in the airways were identified by AB/PAS staining, and photographs were taken from representative slides (objective amplification 310). AB/PAS-positive material in airway epithelia after 10 days were assessed by image analysis (E). Data are expressed as mean scores ± SEM. Bars without same letter are different significantly (p < 0.05). modest, as were the effects on IFNGR. Also, DON did not appear to affect induction of Mx1 and ISG15, even though elevated levels of these genes were observed in lung tissues of reovirus-treated mice. Thus, further exploration into the kinetics of mRNA and protein expression of antiviral genes as well as responsible cell phenotypes is warranted in this model. Severe lung damage, consistent with inflammatory cell infiltration and protein secretion, in DON-treated mice following infection were likely to be mediated, in part, by increased TNF-a and MCP-1 concentrations. TNF-a, a cytokine that plays an important role in many inflammatory diseases, is produced by macrophages, monocytes, dendritic cells, B cells, neutrophils, mast cells, and CD4þ cells (Aggarwal et al., 2002) . Once released in the airway, TNF-a acts by inducing a general inflammatory response through the enhanced release of proinflammatory/chemotactic mediators. In addition, TNF-a upregulates adhesion molecules, such as E-selectin, vascular cell adhesion molecule-1 (VCAM-1), matrix melloproteinase 9 (MMP9), and cyclooxygenase 2 (COX2) (Aggarwal et al., 2002; Russo and Polosa, 2005) , all of which can facilitate the migration of inflammatory cells and pulmonary cell damage. MCP-1 is produced by a wide variety of cell types including monocytes and epithelial cells (Shyy et al., 1993; Taub et al., 1995) . This chemokine promotes migration of monocytes, T cells, neutrophils, and NK cells during inflammatory response (Carr et al., 1994; Loetscher et al., 1994; Taub et al., 1995) . FIG. 8 . DON potentiates reovirus-induced protein and cytokine secretion in murine lung. Mice were treated with DON and reovirus as described in Figure 3 legend. After 3-day PI (A, C, and E) and 7-day PI (B, D, and F), BALF was analyzed for total protein (A and B), MCP-1 (C and D), and TNF-a (E and F). Data are means ± SEM (n ¼ 6). Bars without same letter differ significantly (p < 0.05). ND indicates not detectable.
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Enhanced mucosal and systemic reovirus-specific IgA responses were consistent with several previous investigations demonstrating that chronic DON exposure elevates total serum IgA, fecal IgA, and ex vivo IgA production as well as specific IgA to microbial and self-antigens (reviewed by Pestka, 2003) . IL-6 was assessed here because DON is an highly effective inducer of IL-6 and, furthermore, elevated IL-6 plays a key role in aberrantly increased IgA responses in mice fed DON for extended time periods . Taken together, the current and previous findings suggest that elevated IL-6 in reovirus-infected mice might contribute to increased mucosal and systemic IgA responses. While an enhanced reovirus-specific IgA seems counterintuitive to the observed increases in reovirus, this was an acquired immune response that might impact viral clearance beyond the 10-day window employed here.
Virus-induced mucous cell metaplasia is complex and involves a novel immune axis for growth factor and cytokine production and downstream events that modulate ciliated epithelial cell survival and transdifferentiation (Holtzman et al., 2006) . The results presented here suggest that reovirus evoked prominent mucous cell metaplasia but that this was markedly exacerbated by DON. Both TNF-a and IL-6 can stimulate airway mucin gene expression (Voynow et al., 2006) . It is thus tempting to speculate that DON-mediated increases in these two proinflammatory cytokines contributed to the enhanced mucous cell metaplasia observed in mice cotreated with reovirus and DON.
The mechanisms by which DON upregulates cytokine and chemokine production might be direct or indirect. Regarding direct effects, DON is known to increase gene expression in T cells and macrophages by enhancing both activation of key transcription factors (Li et al., 2000; Ouyang et al., 1996; Wong et al., 2002; Zhou et al., 2003b) and cytokine mRNA stability (Chung et al., 2003a; Li et al., 1997; Wong et al., 2002) . Both enhanced transactivation and mRNA stabilization of immune and inflammatory genes by DON have been linked to activation of p38 and ERK 1/2 MAPKs via the ribotoxic stress response (Chung et al., 2003b; Pestka, 2002, 2003) . Double-stranded RNA activated protein kinase R (Zhou et al., 2003c) and the Src-family tyrosine kinases (Zhou et al., 2005b) are two signaling transducers upstream of the MAPKs that mediate DON's action. The possibility for interaction with reovirus in inducing these intracellular signaling cascades is a potential target for further study. An alternative explanation is that cytokine and chemokine upregulation by DON of might occur indirectly as an outcome of increased reovirus burden. Both direct and indirect mechanisms are not mutually exclusive.
An alternative explanation for DON suppression of host response to reovirus might be increased death of lymphocytes or lung epithelial cells. Since the sublethal DON dose (10 mg/k bw) used for most experiments does not induce apoptosis in thymus, peyer's patches, spleen, or bone marrow (Zhou et al., 1999 , altered reovirus clearance might not be readily explainable by lymphocyte death in the mucosal or systemic immune compartments. However, lymphocyte recruitment was significantly reduced in mice treated with virus and DON compared to mice treated with virus alone. It is possible that DON could synergize with virus or a virus-induced mediator to cause apoptotic death in a critical lymphocyte population. In support of this latter contention, Uzarski et al. (2003) DON-induced lymphocyte apoptosis is amplified by TNF-a, which was upregulated in the model described here.
Since respiratory epithelium is a primary barrier against pathogens and toxins, epithelial damage could facilitate viral infection and exacerbate pathologic sequelae (Becker and Soukup, 1999; Chauhan et al., 2003; Li and Holian, 1998; Miyamoto, 1997; Romieu et al., 2002; Spannhake et al., 2002; Wanner, 1993) . However, histopathological changes were neither evident here nor are there reports that DON induces specific damage or cell apoptosis in lung tissues at the concentrations employed in this study.
In summary, the results presented here suggest that DON compromised resistance to respiratory reovirus infection. Multiple mechanisms might be involved in DON-induced suppression of the antiviral response and resultant downstream sequelae (Fig. 11 ). The pathologic effects described herein would likely increase morbidity and discomfort to a person during the course of respiratory infection and thus are relevant from the perspective of human safety assessment. The finding that as little as 2 mg/kg bw of DON potentiated reovirus L 2 RNA levels in lung is consistent with the threshold for immunosuppression observed previously for this toxin in the reovirus-GI model (Li et al., 2005) . Thus, both studies suggest that a relatively low dose of DON was sufficient to increase the viral burden in the mouse. This dose would be equivalent to consumption of 13 ppm of DON in mouse diet over the course of 1 day. DON concentrations exceeding these values have been found in contaminated human food samples (Abouzied FIG. 10 . DON potentiates reovirus-induced IL-6 protein secretion and lung IL-6 mRNA expression in mouse. Mice were treated with DON and reovirus as described in Figure 3 legend. BALF (A and B) and lung (C and D) were collected after 3 days (A and C) and 7 days (B and D) and analyzed for IL-6 protein (A and B) and IL-6 mRNA (C and D), respectively. Data are means ± SEM (n ¼ 6). Bars or points without same letter differ significantly at same time point (p < 0.05).
FIG. 11.
Summary of DON's effects on immune responses and pathologic sequelae to intranasal reovirus instillation. First, increased reovirus infection might result from interference with type 1 IFN-mediated responses involving the PKR pathway and OAS system, which would enhance viral replication and suppress virus clearance from lung. Second, elevations in both TNF-a and MCP-1 could contribute to increased severity of alveolar damage and inflammatory cellular infiltration. Third, corresponding increases in IL-6 might concurrently amplify reovirus-specific IgA production. Finally, both TNF-a and IL-6 could contribute to mucous cell metaplasia. Elevation of cytokines could result directly from DON exposure or indirectly by the DON-mediated increase in viral burden. et al., 1991) . From a safety assessment perspective, additional studies are needed to determine how chronic low-dose exposure to DON might impact host resistance to reovirus. Another critical question that remains to be answered relates to how the toxin might modulate host resistance to other respiratory viruses such as influenza and enhance their pathologic effects.
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